Cargando...
Therapeutic Potential of Targeting the Ghrelin Pathway
Ghrelin was discovered in 1999 as the endogenous ligand of the growth-hormone secretagogue receptor 1a (GHSR1a). Since then, ghrelin has been found to exert a plethora of physiological effects that go far beyond its initial characterization as a growth hormone (GH) secretagogue. Among the numerous w...
Guardado en:
| Publicado en: | Int J Mol Sci |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
MDPI
2017
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5412382/ https://ncbi.nlm.nih.gov/pubmed/28398233 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms18040798 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|